Cranioplasty using OSSDSIGN® Cranial - preliminary data from a retrospective study


In a retrospective study of patients undergoing cranioplasty using OSSDSIGN Cranial, 96,7% of patients treated showed no signs of post-operative complications leading to implant removal at an average follow-up time of 9,5 months. This indicates that OSSDSIGN Cranial may provide a better, more permanent solution for cranioplasty, even in a complex patient population.

This preliminary data is part of a larger retrospective study which will be published and presented once completed. The preliminary data will be available in the OssDsign booth (#1) at EANS 2016 (the 16th European Congress of Neurosurgery, in Athens, Greece, 4th - 8th September 2016). 

For more information, please contact OssDsign at or